Message from the Editor

Welcome to the summer edition of e-Parkinson Post. It has been an exciting couple of months. We had a very successful Parkinson’s Awareness Month, with many of you joining us in activities such as education sessions, lectures, tulip sales and the opening of the Toronto Stock Exchange, where we raised awareness among the corporate sector. … Read more

My 31-year experience with Dr. Stanley Fahn

By Judy Hazlett I’m privileged to know Dr. Fahn as a compassionate physician, one who has treated me as a patient with respect and understanding. Dr. Fahn diagnosed me with Parkinson’s disease 31 years ago almost to the day, so we’ve known each other a long time. No matter how bizarre my behaviours became with … Read more

Donald Calne Lecture: Individualized treatment best approach in Parkinson’s

Parkinson’s disease is a complex disease that requires individualized treatment. “No two people are alike. You have to decide what each person needs and treat accordingly.” That was the over-riding message of the 8th Donald Calne Lecture delivered by Dr. Stanley Fahn, the H. Houston Merritt Professor of Neurology and Director of the Centre for … Read more

Movement Disorder Society holds Congress in Toronto

The 15th International Congress of Parkinson’s Disease and Movement Disorders was held in Toronto, from June 5th to 9th. To see Parkinson’s-related news from the Congress, visit Movement Disorder Society Toronto 2011 Congress – News Releases.

Exciting new Parkinson’s research in Canada

Several new and innovative research projects are underway or recently completed. For example: An international study led by Dr. Michael Schlossmacher, who holds the Canada Research Chair in Parkinson’s disease at the Ottawa Hospital Research Institute and the University of Ottawa in Ottawa, has provided the first link between the most common genetic risk factor … Read more

Medication Alert: Major changes to Sinemet and Levocarb

If you take Sinemet or the generic form Levocarb, please be aware that, over the past 18 months, the supply of Sinemet and Levocarb has changed; the markings on the Sinemet CR (controlled release) and Sinemet IR (immediate release) pills have also changed. These changes include new colours, shapes, markings, non-medicinal ingredients and storage conditions. … Read more

In the News

Parkinson’s isn’t a homogenous disease An interview with Dr. Francesca Cicchetti, Associate Professor and researcher at Laval University, in Tandem, the English-language complement to Corriere Canadese, Canada’s Italian newspaper. New insights into Parkinson’s Parkinson’s Disease: Why Dopamine Replacement Therapy Has a Paradoxical Effect On Cognition Potential Cause of Severe Sleep Disorder Discovered, Implications for Parkinson’s … Read more

Educational resources now available in additional languages

Parkinson’s: the Facts Progression of Parkinson’s Disease Information Sheet Parkinson’s Medications – What you need to know! Taking Control – 10 steps to help you cope with a recent diagnosis of Parkinson’s These resources are now available online in Chinese, German, Italian, Punjabi and Spanish, in addition to English and French, making them accessible to … Read more